Finance committee  First of all, I think we should talk about the financial investment we're requesting the government to make. It's $30 million a year over five years. That is really less than $1 per Canadian, per year, for a disease that's already costing well over $1,000. So it's a modest invest

Finance committee  Good morning, Mr. Chair. On behalf of the Alzheimer Society of Canada, let me thank you all for the opportunity to appear before you and the members of this committee today. We did submit a pre-budget submission. We recommended that the government invest $150 million over five y

International Trade committee  I would say I certainly hope so. There are really only four medications that are available to people right now, and they are of limited value to people. We often say the non-pharmacological treatments are of more value to people than those that are available, but we do know that

International Trade committee  We have a research competition every year that we run. Our research is primarily investigator driven, so our researchers come to us, provide us with an idea, make application, and we fund their research.

International Trade committee  We partner primarily with the Canadian Institutes of Health Research and the new Canadian Consortium on Neurodegeneration in Aging, which is the latest project to really come forward to provide funds for dementia research.

International Trade committee  It's a possibility and it's certainly something we would have to look into. We do have very close relationships with international research funding bodies all over the world. Through the American Alzheimer's Association, we're part of an international funders group.

International Trade committee  I would hope it would make it easier. As we said, the devil is in the details, so we hope that it would make it easier for us.

International Trade committee  Thank you.

International Trade committee  Yes, absolutely. I think our major wish for Canadians who are living with this disease is that they have access to hope. I think that is the thing. You heard also from Durhane of the same kinds of issues. When we don't know the cause or the cure for a disease, hope is the best t

International Trade committee  Good morning. Thank you very much to the members of this committee for the invitation to appear here today. I'm happy to be here again, and I'm pleased to see that significant progress has been made on CETA since the last time I was here. Before I begin, I'd just like to take a